Authors: Tsai, DE Hardy, CL Tomaszewski, JE Kotloff, RM Oltoff, KM Somer, BG Schuster, SJ Porter, DL Montone, KT Stadtmauer, EA

Citation: De. Tsai et al., Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients, TRANSPLANT, 71(8), 2001, pp. 1076-1088

Authors: Stadtmauer, EA Tsai, DE Sickles, CJ Mick, R Luger, SM Porter, DL Mangan, PA Schuchter, LM Schuster, SJ Loh, EY Magee, DA Sachs, RA Wall, ME Moore, J Buzby, GP Zaleta, E Kamoun, M Silberstein, LE

Citation: Ea. Stadtmauer et al., Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination, MED ONCOL, 16(4), 1999, pp. 279-288

Authors: Tsai, DE Moore, HCF Hardy, CL Porter, DL Loh, EY Vaughn, DJ Luger, S Schuster, SJ Stadtmauer, EA

Citation: De. Tsai et al., Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation, BONE MAR TR, 24(5), 1999, pp. 521-526

Authors: Tsai, DE Stadtmauer, EA Canaday, DJ Vaughn, DJ

Citation: De. Tsai et al., Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder, MED ONCOL, 15(4), 1998, pp. 279-281